Search News Archives
IT Solutions and Laboratory Automation
Conferences | Events
Siemens RAPIDLab Systems Now Include Whole Blood Neonatal Bilirubin Testing
Deerfield, Ill., February 26, 2010 - Siemens RAPIDLab® 1200 series blood gas analyzers offer neonatal bilirubin (nBili) testing that detects elevated levels of bilirubin with a 60 second turnaround time. If undetected, elevated bilirubin can lead to a variety of health issues in newborn infants, from jaundice to neurological disorders and, in severe cases, brain damage.
Siemens nBili test provides fast, accurate results without increasing monthly operating costs. This Siemens test requires only 100uL sample of whole blood measuring 2 - 30 mg/dl and can be conducted as part of a neonatal test panel that includes blood gas, pH, electrolytes, metabolites, total hemoglobin and CO-oximetry. No additional reagents or sample preparation are needed for this Siemens nBili test. For additional information, visit www.usa.siemens.com/bloodgas.The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit: www.siemens.com/healthcare.